Dr Rozenblit on Pembrolizumab Outcomes by TMB Status in HR+ Metastatic Breast Cancer Dr Lloyd on the Effects of ESR1 Mutations on Elacestrant Outcomes in HR+ Advanced Breast Cancer Unveiling the Latest in HER2+ Breast Cancer and Beyond With Drs Sara Hurvitz and Neil Iyengar ...
Moe MM, Pwint P, Leonard RC. Treatment options for older woman with early breast cancer. Expert Rev Anticancer Ther. 2006;6:941-50.M MyatMoe, T PwintPwint, RCFLeonard. (2006) Treatment options for older woman with early breast cancer. Expert Review of Anticancer Therapy 6 , 941-950 /...
For patients with early-stage breast cancer who are considered high-risk for distant disease recurrence and risk of death, the use of pCR an measure of clinical efficacy may predict clinical benefit within several months of treatment, addressing unmet treatment needs in a shorter timeframe compared...
948 USE OF A DECISION AID REGARDING TREATMENT OPTIONS FOR EARLY PROSTATE CANCER: A SINGLE-INSTITUTIONAL REPORT ON PATTERN OF TREATMENT CHOICE IN 230 PATIENTS Purpose: To evaluate outcomes of low-risk prostate cancer patients managed with competing treatments, in a single institution. Methods: Patients...
Estimately, 70–80% of cancer cases are diagnosed in late stages in Kenya with breast cancer being a common cause of mortality among women where late diagnosis is the major ubiquitous concern. Numerous studies have focused on epidemiological and health p
Introduction Advances in the evaluation and treatment of breast cancer have made the clinical decision-making context much more complex.1,2 Options for all modalities of treatment, including surgery, drug therapy, radiation, and reconstruction, have markedly expanded, as have preventive options for wom...
Mammograms are one of the best forms of prevention and early detection of breast cancer. Women at average risk of breast cancer should begin mammogram screening
Early access is a potential pathway for patients diagnosed with a serious and/or life-threatening disease or condition to gain access to an investigational product for treatment outside of a clinical trial when no comparable or satisfactory alternative therapy options are available. In these instances...
A proactive approach to detecting cancer at an early stage can make treatments more effective, with fewer side effects and improved long-term survival. However, as detection methods become increasingly sensitive, it can be difficult to distinguish incons
Erin Kennedy7 and Eva Grunfeld1,2 Abstract Background: For early stage breast cancer, randomized controlled trials (RCTs) have shown that patient decision aids (PtDAs), when used by surgeons, result in increased patient knowledge about options and different patient treatment choices as compared to...